SCHEMBL30459591

SCHEMBL30459591

ClCCCCc1ccc(N2CCNCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 6/20 0.53
SIGMAR1 Q99720 5/20 0.53
HTR3E A5X5Y0 3/20 0.53
HTR3B O95264 3/20 0.53
HTR3A P46098 3/20 0.53
HTR3D Q70Z44 3/20 0.53
HTR3C Q8WXA8 3/20 0.53
CETP P11597 2/20 0.46
LTA4H P09960 3/20 0.45
ADRB2 P07550 1/20 0.44
NCF1 P14598 1/20 0.44
PLD1 Q13393 1/20 0.44
HTR1A P08908 1/20 0.43
DRD2 P14416 1/20 0.43
DRD1 P21728 1/20 0.43
DRD5 P21918 1/20 0.43
HTR2A P28223 1/20 0.43
DRD3 P35462 1/20 0.43
TMEM97 Q5BJF2 1/20 0.43
CHRNB2 P17787 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7433560 0.83 ADRB1 (0.49) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL5717512 0.83 S1PR1 (0.56) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL27519086 0.82 S1PR1 (0.58) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL177143 0.82 S1PR1 (0.58) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL3716245 0.81 CETP (0.57) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL3123141 0.81 ADRB1 (0.50) ADRB1SIGMAR1HTR3EHTR3BHTR3A
Bromide SCHEMBL7337699 0.81 S1PR1 (0.57) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL7927296 0.80 ADRB1 (0.62) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL7510335 0.80 SIGMAR1 (0.43) SIGMAR1HTR1ADRD2DRD1DRD5
Hydrochloric Acid SCHEMBL3118726 0.80 ADRB1 (0.49) ADRB1SIGMAR1HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 WO disclosed